Juventas Therapeutics Raises $22.2 Million Series B Financing
PR Newswire (press release)
CLEVELAND, July 16, 2012 /PRNewswire/ -- Juventas Therapeutics, a clinical-stage regenerative medicine company, announced today that it has closed a $22.2 million Series B financing that was co-led by Triathlon Medical Venture Partners and New ...


More...